Open menu
Paytm Money logo
Download App
Reliance Mutual Fund

Reliance Pharma Fund Direct-Growth

NAV
returns change indicator
149.8528
as on 21 May 2019 09:15 PM
0.3288(0.22%)
Last Change
Scheme Ratings
medal
1
Pharma
by returns in last 5 years
Investment Performance
would have given a returns of
110,871
star
121,647
star
108,240
star
111,132
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
11,132
Profit (absolute return)
11.13%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm Money
Investment Returns
In the last 3 months
3.64%
In the last 6 months
6.96%
In the last 1 year
7.40%
In the last 3 years
11.13%
In the last 5 years
73.10%
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low
moderately low
moderately low
moderate
moderate
moderately high
moderately high
high
high
indicator
Investors understand that their principal will be at high risk
Scheme Information
Reliance Pharma Fund Direct-Growth
Reliance Pharma Fund Direct-Growth
as of 21 May 2019 09:15 PM
2,710.65 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 1 year
1.37%
Expense Ratio
Plan
Growth
0.39%
Cash Holding
Benchmark
S&P BSE Healthcare Total Return Index
Scheme Document
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 1 year
Scheme Document
Sectors Holding in this Mutual Fund
as on 30 Apr 2019
Sort By
Healthcare
97.55%
2,644.23 Cr
Financial
1.70%
46.08 Cr
Cash Holding
0.39%
10.57 Cr
Sectors Holding in this Mutual Fund
as on 30 Apr 2019
Sort By
Healthcare
97.55%
2,644.23 Cr
Financial
1.70%
46.08 Cr
Cash Holding
0.39%
10.57 Cr
Companies Holding in this Mutual Fund
as on 30 Apr 2019
Sort By
Sun Pharmaceutical Inds. Ltd.
11.20%
303.59 Cr
Divi's Laboratories Ltd.
11.18%
303.05 Cr
Aurobindo Pharma Ltd.
9.36%
253.72 Cr
Cipla Ltd.
9.27%
251.28 Cr
Dr. Reddy's Laboratories Ltd.
7.41%
200.86 Cr
Syngene International Ltd.
6.89%
186.76 Cr
Biocon Ltd.
6.31%
171.04 Cr
Sanofi India Ltd.
6.30%
170.77 Cr
Lupin Ltd.
6.02%
163.18 Cr
Abbott India Ltd.
5.55%
150.44 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 30 Apr 2019
Sort By
Sun Pharmaceutical Inds. Ltd.
11.20%
303.59 Cr
Divi's Laboratories Ltd.
11.18%
303.05 Cr
Aurobindo Pharma Ltd.
9.36%
253.72 Cr
Cipla Ltd.
9.27%
251.28 Cr
Dr. Reddy's Laboratories Ltd.
7.41%
200.86 Cr
Syngene International Ltd.
6.89%
186.76 Cr
Biocon Ltd.
6.31%
171.04 Cr
Sanofi India Ltd.
6.30%
170.77 Cr
Lupin Ltd.
6.02%
163.18 Cr
Abbott India Ltd.
5.55%
150.44 Cr
View All
View All
About Reliance Pharma Fund Direct-Growth
Reliance Pharma Fund Direct-Growth is a Equity mutual fund scheme from Reliance Mutual Fund. This scheme was launched on 01 Jan 2013 and is currently managed by its fund manager Sailesh Raj Bhan. It has an AUM of ₹2,710.65 Crores and the latest NAV decalared is ₹149.853 as on 21 May 2019 at 9:15 pm.
Reliance Pharma Fund Direct-Growth scheme return performance in last 1 year is 7.40%, in last 3 years is 11.13% and 114.49% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.
Scheme Objective
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
AMC Information
Reliance Mutual Fund
Reliance Mutual Fund
View AMC Details
225,417.81 Cr
AUM
191
Schemes
Address
Address
Reliance Centre, 7th Floor, South WingOff Western Express HighwaySantacruz (East)400055
Phone Number
Phone Number
Phone : (022) 33031000 / 1800 300 11111
Fax : (022) 33037662